Pacira BioSciences, Inc. (PCRX)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,553,520 | 1,574,390 | 1,681,200 | 2,075,350 | 1,274,510 |
| Total stockholders’ equity | US$ in thousands | 778,348 | 870,130 | 775,010 | 730,408 | 619,688 |
| Financial leverage ratio | 2.00 | 1.81 | 2.17 | 2.84 | 2.06 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,553,520K ÷ $778,348K
= 2.00
The financial leverage ratio of Pacira BioSciences, Inc. has shown some variability over the years. From 2020 to 2021, there was a significant increase from 2.06 to 2.84, indicating a higher level of financial leverage. This could suggest that the company increased its reliance on debt to finance its operations or investments during that period.
In 2022, the financial leverage ratio decreased to 2.17, indicating a slight reduction in the company's debt usage compared to the previous year. However, by 2023, the ratio declined further to 1.81, signaling potentially lower debt levels relative to the company's equity.
Finally, in 2024, the financial leverage ratio increased slightly to 2.00, indicating a moderate increase in debt usage compared to the previous year. Overall, the trend in Pacira BioSciences' financial leverage ratio shows fluctuations in the company's debt levels relative to its equity over the years, with varying implications for its financial risk and capital structure.
Peer comparison
Dec 31, 2024